Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-12
2009-12-22
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S341000, C546S272400, C546S148000
Reexamination Certificate
active
07635703
ABSTRACT:
The present invention is directed to novel substituted pyrazole compounds of Formula (I) or a form or composition thereofand the use thereof as inhibitors of ATP-protein kinase interactions.
REFERENCES:
patent: 4999269 (1991-03-01), Emoto et al.
Caligiuri et al., Chemistry & biology, (Oct. 2005) vol. 12, No. 10, pp. 1103-1115.
Lin et al., Design, Synthesis, and Evaluation of 3,4-Disubstituted Pyrazole Analogues as Anti-Tumor CDK Inhibitors, Bioorganic & Medicinal Chemistry Letters (2007), vol. 17, pp. 4557-4561.
International Search Report dated Aug. 7, 2008 for International Appln. No. PCT/US2007/21848.
Connolly Peter J.
Lin Ronghui
Yu Yang
Janssen Pharmaceutica N.V.
Kamage Andrea Jo
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Imidazole substituted pyrazole kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole substituted pyrazole kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole substituted pyrazole kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4079383